Read more
Informationen zum Autor Franz-Josef Zimmer, Steven M Zeman, Jens Hammer, Klara Goldbach and Bernd Allekotte Klappentext Both legislators and the Boards of Appeal of the European Patent Office have invested considerable effort over the last two decades to adjust the law and practice governing life science inventions to the rapidly changing technological landscape. This book provides an introduction to life science patent practice and jurisdiction in Europe according to PCT, EPC and secondary EU law. This book aims to help experts and corporations in the field of life sciences to convert their research into protective, enforceable rights in Europe. It conveys a sense of the requirements for patentability and the issues influencing patent enforcement by presenting illustrative examples of relevant decisions and claims. Thus, while clearly addressing patent professionals, the book serves as a starting point for readers requiring general guidance as to the factors influencing patent protection for life science inventions, and examples of claim language used. Where the first edition focused primarily on biotechnological subject matter, the second edition addresses the broader field of life sciences. It also includes a new chapter on the enforcement of patent rights throughout Europe and an outline of the forthcoming Unitary Patent and Unified Patent Court system. Inhaltsverzeichnis Abbreviated Table of Contents: A. Life Science Matter A.I. Summary of historical development A.II. Definition of life science matter B. Legal Provisions B.I. European Patent Convention (EPC) B.II. EU Law (EU Biotech Directive and its Implementation into the EPC; EU Regulations Concerning the Creation of a Supplementary Protection Certificate [SPC] for Medicinal Products [MSPC], Pediatric Extension of Duration for Medicinal Products [PE] and Plant Protection Products [PSPC]; Council Regulation on Community Plant Variety Rights [CPVR]; EU Bolar Directive) C. General Aspects on Protection C.I. Protection under the EPC C.II. Protection under the EU Regulations D. Protectable Matter in the Life Sciences D.I. Small Molecules and Polymers D.II. Nucleic acids D.III. Proteins D.IV. Antibodies D.V. Microorganisms D.VI. Plants D.VII. Animals D.VIII. Human Body E. Patent Infringement E.I. Introduction (Pre-Suit Considerations; Cross-Border Issues; General Principles - limited territorial reach; Cross-Border Injunction; Torpedo Actions) E.II. Scope of Protection (Claim Construction and Literal Infringement; Equivalent Infringement and Purposive Construction; Specific Claim Categories; Product Claims/Compound Claims; Composition claims; Product-by-Process Claims; Second Medical Use Claims/"Off label" Use; Companion Diagnostic Claims; Screening Processes and Reach Through Claims; SPCs; Plant Variety Rights; Effects of the Patent; Issues particular to life sciences; Bolar Provision; Experimental Use; Research Tools ; EU Biotech Directive; Limitations of patent protection available to gene sequences - the Monsanto-decision) E.III. Enforcement options (Introduction; Cease and Desist Letter; Criminal Proceedings; Border Seizure; Decision on the merits; Bifurcation; Discovery; Preliminary Relief/Preliminary Injunctions) E.IV. Antitrust Law (Introduction; Sector Inquiry [Pharmaceuticals]; "Pay-for-delay"/Lundbeck decision) E.V. Unitary Patent and Unified Patent Court (Introduction; Language; Unified Patent Court ; Structure Jurisdiction Transitional Period and "opt out"; Panels ; Sources of Law; Provisional Measures; Parties and their Representation before the UPC; Procedural Issues) ANNEX (EPC: Articles and Rules concerning Patentability, Biological sequences, Biolog...
